Study flags cancer risk in female orthopedists New drug delivery system: the nanosponge? New protease inhibitor showing promise for hepatitis C Early study suggests experimental drug telaprevir offers option for patients who have not responded to standard treatment Hybrid therapy tops for H. pylori infection Two-week combined strategy achieves superior eradication rates How much do adverse events cost? Focused research to determine economics of patient safety Three of 5 nurses in Florida are leaving the state's work force Sponge-derived drug extends breast cancer survival Elderly lung cancer patients benefit from aggressive chemo 'Remarkable' four-month improvement in survival will change practice, researchers say Canadian researchers disagree on halting rosiglitazone trial Canadian researchers disagree on halting trial of diabetes drug rosiglitazone ‘Presumed consent’ is really just theft First Previous 856 857 858 859 860 Next Last
